DAPSONE
- Product NDC
- 0904-7019
- 11-digit product format
- 009047019
- Labeler code
- 0904
- Product ID
- 0904-7019_6ea0a297-f19b-4ae3-8fe3-f1ecee36302c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Dapsone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Major Pharmaceuticals
- Application
- ANDA206505
- Marketing category
- ANDA
- Marketing start
- 2018-01-15
- Marketing end
- 0000-00-00
- Substance
- DAPSONE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Sulfone [EPC],Sulfones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0904-7019-46 | 00904701946 | 30 TABLET in 1 BOTTLE (0904-7019-46) | 30 tablet | 2018-01-15 | 0000-00-00 | No | No | Current |
| 0904-7019-59 | 00904701959 | 100 TABLET in 1 BOTTLE (0904-7019-59) | 100 tablet | 2018-01-15 | 0000-00-00 | No | No | Current |